What's Happening?
Adisseo's probiotic solution, Alterion® NE, is celebrating its tenth anniversary since its commercial introduction in poultry production. The product, which utilizes the Bacillus subtilis DSM 29784 strain, has consistently demonstrated benefits in improving
gut health, growth performance, and feed efficiency in poultry across various regions and production systems. Its mode of action focuses on three pillars of intestinal resilience: microbial ecology, gut morphology and intestinal integrity, and inflammatory response. The probiotic supports beneficial microbial populations, stimulates bacterial communities for nutrient utilization, and helps maintain gut integrity by supporting tight-junction proteins. Additionally, it contributes to a controlled inflammatory response, enabling birds to better cope with stress. The success of Alterion® NE is attributed to a rigorous microbial screening program that identified a resilient strain capable of withstanding feed manufacturing conditions and remaining viable in the poultry intestine.
Why It's Important?
The sustained success of Alterion® NE over a decade highlights a significant advancement in animal agriculture, particularly for the U.S. poultry industry. Improved gut health and feed efficiency directly translate to enhanced productivity and economic returns for poultry producers. By strengthening the resilience of birds against common stressors, the probiotic contributes to more uniform flocks and predictable production outcomes, which are crucial for maintaining stable supply chains and competitive pricing in the U.S. market. This innovation also underscores a broader shift in the animal nutrition sector towards science-based solutions that integrate animal health and nutrition, potentially influencing regulatory approaches and research priorities for feed additives in the U.S. The consistent performance and scientific validation of such products can lead to wider adoption of probiotic solutions, impacting the overall sustainability and profitability of the U.S. poultry industry.
What's Next?
Looking ahead, Adisseo plans to expand the application of Alterion® NE to additional animal species and explore new markets. Future developments will also include optimizing probiotic formulations and continuing research into microbial mechanisms and gut resilience. This ongoing research and development could lead to new applications and improved products, further benefiting the U.S. livestock industry beyond poultry. The company aims for Alterion® NE to contribute to the long-term development of its animal health portfolio, supporting sustainable livestock production globally. The continued scientific validation and regulatory endorsements, such as the positive assessment by the European Food Safety Authority (EFSA) in 2018, are likely to encourage further adoption and potentially influence similar assessments and approvals in the U.S., paving the way for broader market penetration and impact.
Beyond the Headlines
The decade-long success of Alterion® NE signifies a deeper trend in agricultural science: the increasing reliance on microbial solutions to enhance animal health and productivity. This approach moves beyond traditional methods by leveraging the intricate biology of the gut microbiome, offering a more sustainable and potentially less antibiotic-dependent pathway for livestock management. The focus on 'intestinal resilience' suggests a holistic view of animal well-being, which could have ethical implications for animal welfare standards and consumer perceptions of agricultural practices. Furthermore, the identification of bioactive metabolites produced by the probiotic strain opens avenues for understanding the complex interactions between diet, microbiome, and host health, potentially leading to breakthroughs in human gut health research. This convergence of animal and human health insights could drive interdisciplinary research and innovation, shaping future nutritional and medical strategies.
